MEGAN FELTS: Open Payments
NPI 1427770965 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,265 in 143 payments from 22 companies in 2025. Trend: 2023 $52 · 2024 $15 · 2025 $2,265
Food & beverage: $2,265
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 23 | $376 |
| ABBVIE INC. | 29 | $324 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $254 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 19 | $193 |
| Madrigal Pharmaceuticals | 8 | $184 |
| Celltrion USA Inc. | 11 | $161 |
| Aimmune Therapeutics, Inc. | 6 | $140 |
| Intercept Pharmaceuticals, Inc. | 5 | $101 |
| Phathom Pharmaceuticals, Inc. | 6 | $79 |
| Gilead Sciences, Inc. | 4 | $75 |
Products named: TREMFYA, XIFAXAN, REZDIFFRA, ENTYVIO, VEGZELMA, LINZESS, ZENPEP, OCALIVA.
Industry payments across TN — which companies pay providers there.
